Acitretin therapy is effective for associated with human immunodeficiency virus infection

Archives of Dermatology

Volumn 133, Issue 6, 1997, Pages 711-715

  Buccheri, Laura ^a   Katchen, Bradford R ^a   Karter, Andrew J ^b   Cohen, Steven R ^a,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b KAISER PERMANENTE   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; PSORIASIS;

EID: 0030912470     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.6.711     Document Type: Article

References (33)

1. Sadick NS, McNutt NS, Kaplan MH. Papulosquamous dermatoses of AIDS. J Am Acad Dermatol. 1990;22:1270-1277.
2. Goodman DS, Teplitz ED, Wishner RS, Klein RS, Burk PG, Hershenbaum E. Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol. 1987;17:210-220.
3. Farber MF, Nall L. Psoriasis associated with immunodeficiency virus/acquired immunodeficiency syndrome. Cutis. 1993;52:29-35.
4. Smith K, Skelton HG, Yeager J, et al. Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. J Am Acad Dermatol. 1994;31:746-754.
5. Johnson TM, Duvic M, Rapini RP. AIDS exacerbates psoriasis. N Engl J Med. 1985;313:1415.
6. Duvic M, Johnson TM, Rapini RP, et al. Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. Arch Dermatol. 1987;123:1622-1632.
7. Lazar AP, Roenigk HH. AIDS and psoriasis. Cutis. 1987;39:347-351.
8. Lazar AP, Roenigk HH. Acquired immunodeficiency syndrome (AIDS) can exacerbate psoriasis. J Am Acad Dermatol. 1988;18:144.
9. Obuch ML, Maurer TA, Becker B, Berger TG. Psoriasis and human immunodeficiency virus infection. J Am Acad Dermatol. 1992;27:667-673.
10. Reveille JD, Conant M, Duvic M. Human immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter's syndrome: a disease continuum? Arthritis Rheum. 1990;33:1574-1578.
11. Belz J, Breneman DL, Nordlund JJ, Solinger A. Successful treatment of a patient with Reiter's syndrome and acquired immunodeficiency syndrome using etretinate. J Am Acad Dermatol. 1989;20:898-903.
12. Williams HC, du Vivier AWP. Etretinate and AIDS-related Reiter's disease. Br J Dermatol. 1991;184:389-392.
13. Cohen P, Sande M, Volberding P. Clinical Spectrum of HIV Disease. 2nd ed. San Francisco: University of California; 1994:1-15.
14. Siiler MJ, Joseph HJ. PASI: what is it, and why do you need to know about it? Fitzpatrick's J Clin Dermatol. 1994;3:40-41.
15. Pilkington T, Brogden RN. Acitretin: a review of its pharmacology and therapeutic use. Drugs. 1992;43:597-627.
16. Winchester R, Bernstein DH, Fischer HD, Enlow R, Solomon G. The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med. 1987;106:19-26.
17. Valerie K, Delers A, Bruck C, et al. Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature. 1988;333:78-81.
18. Vogel J, Cepeda M, Tschachler E, Napolitano LA, Jay G. UV activation of human immunodeficiency virus gene expression in transgenic mice. J Virol. 1992;66:1-5.
19. Morrey JD, Bourn SM, Bunch TD, et al. UV activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice. J Virol. 1991;65:5045-5051.
20. Zmudzka BZ, Beer JZ. Activation of human immunodeficiency virus by ultraviolet radiation. Photochem Photobiol. 1992;52:1153-1162.
21. Shupack JL, Stiller MJ, Haber RS. Psoriasis and Reiter's syndrome. Clin Dermatol. 1991;9:53-58.
22. Diez F, del Hoyo M, Serrano S. Zidovudine treatment of psoriasis associated with acquired immunodeficiency syndrome. J Am Acad Dermatol. 1990;22:146-147.
23. Duvic M, Crane MM, Conant M, Mahoney SE, Reveille JD, Lehrman SD. Zidovudine improves psoriasis in human immunodeficiency virus-positive males. Arch Dermatol. 1994;130:447-451.
24. Fredriksson T, Pettersson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica. 1978;157:238-244.
25. Gollnick H, Bauer R, Brindley C, et al. Acitretin versus etretinate in psoriasis. J Am Acad Dermatol. 1988;19:458-469.
26. Chou RC, Wyss R, Huselton CA, Wiegand UW. A newly discovered xenobiotic metabolic pathway: ethyl ester formation. Life Sci. 1991;49:169-172.
27. Larsen FG, Jakobsen P, Knudson J, Weismann K, Kragballe K, Nielson-Kudsk F. Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol. J Invest Dermatol. 1993;100:623-627.
28. Murray EH, Anhalt AW, Lessard R, et al. A 12-month treatment of severe psoriasis with acitretin. J Am Acad Dermatol. 1991;24:598-602.
29. Grunfeld G, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 1992;74:1045-1052.
30. Grunfeld G, Feingold KR. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med. 1992;327:329-337.
31. Fischl M. An introduction to the clinical spectrum of AIDS. In: Broder S, Merigan TC, Bolognesi D, eds. Textbook of AIDS Medicine. Baltimore, Md: Williams & Wilkins; 1994:149-159.
32. Coldiron BM, Bergstresser PR. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch Dermatol. 1989;125:357-361.
33. Colebunders R, Blot K, Mertens V, Dockx P. Psoriasis regression in terminal AIDS. Lancet. 1992;339:1110.